Balchem CorporationBCPC
About: Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Employees: 1,379
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
400% more call options, than puts
Call options by funds: $5.56M | Put options by funds: $1.11M
150% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 5 (+3) [Q1 2025]
87% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 30
4% more funds holding
Funds holding: 354 [Q4 2024] → 367 (+13) [Q1 2025]
9% more repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 120
1% less capital invested
Capital invested by funds: $4.73B [Q4 2024] → $4.69B (-$35.1M) [Q1 2025]
2.2% less ownership
Funds ownership: 89.43% [Q4 2024] → 87.23% (-2.2%) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Raghuram Selvaraju | 7%upside $180 | Buy Maintained | 28 Apr 2025 |
Financial journalist opinion
Based on 3 articles about BCPC published over the past 30 days
